Related Experiment Video
Updated: May 2, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
[Advance in research on spinocerebellar ataxia 17]
1Movement Disorder & Neurogenetics Research Center, China-Japan Friendship Hospital, Beijing 100029, P.R.China. jane55.gu@vip.sina.com.
Abstract:
Hereditary spinocerebellar ataxia type 17 (SCA17) is an autosomal dominantly inherited progressive degenerative disease of the nervous system. Also known as Huntington's disease-like 4(HDL4), SCA17 mainly features ataxia, muscle dystonia and psychiatric symptoms. The gene predisposing to SCA17 has been mapped and cloned, which encodes a TATA-binding protein (TBP). A CAG repeat expansion in the coding region of TBP gene can cause polyglutamine chain extension in the protein. This paper reviews recent progress in the research on SCA17 in regard to its clinical, etiology, pathology and pathogenesis.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Spinal Cord Injury ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction

